E-ISSN 2231-3206 | ISSN 2320-4672
 

Original Research 


Cost variation analysis of various brands of anticoagulants, fibrinolytics, and antiplatelet drugs currently available in Indian pharmaceutical market

Deepak K R, Geetha A.

Abstract
Background: Cardiovascular disease is both highly prevalent and expensive to treat. Many novel anticoagulants, fibrinolytics, and antiplatelet agents have been found to be effective in decreasing the morbidity and mortality associated with cardiovascular disease. In the Indian market, there is large variation in the prices of anticoagulants, fibrinolytics, and antiplatelet drugs marketed in India.

Aims and Objectives: Thus, a study was conducted to find out the variation in cost in the anticoagulants, fibrinolytics, and antiplatelet drugs available in India and to evaluate the difference in cost of various brands of the same anticoagulants, fibrinolytics, and antiplatelet drugs by calculating percentage variation in cost.

Materials and Methods: Cost of a particular drug in the same strength and dosage forms being manufactured by different companies was obtained from “current index of medical specialties” January to April 2017 edition. Minimum and maximum price of anticoagulants, fibrinolytics, and antiplatelet drugs manufactured by different pharmaceutical companies, and percentage cost variation was calculated.

Results: The cost of anticoagulants, fibrinolytics, and antiplatelet drugs by different companies was different. The highest percentage of cost variation was for tablet clopidogrel (75 mg) 394.61%, followed by tablet acenocoumarol (3 mg) 171.70%, injection enoxaparin sodium (60 mg/0.6 ml) 143.68%, tablet aspirin (75 mg) 51.55%, and lowest percentage cost variation was observed for injection streptokinase (1.5 MIU) 1.31%.

Conclusion: There is lot of variation in the prices of different brands of the same anticoagulants, fibrinolytics, and antiplatelet drugs currently available in Indian market. Despite the implementation of price control, brand price variations still exist widely for commonly used drugs. Reassessment of pricing policy and implementation of quality norms is required.

Key words: Anticoagulants; Fibrinolytics; Antiplatelet Drugs; Cost Analysis; Cost Variation


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Deepak K R
Articles by Geetha A
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

R DK, A G. Cost variation analysis of various brands of anticoagulants, fibrinolytics, and antiplatelet drugs currently available in Indian pharmaceutical market. Natl J Physiol Pharm Pharmacol. 2019; 9(5): 368-372. doi:10.5455/njppp.2019.9.0205602032019


Web Style

R DK, A G. Cost variation analysis of various brands of anticoagulants, fibrinolytics, and antiplatelet drugs currently available in Indian pharmaceutical market. http://www.njppp.com/?mno=32277 [Access: December 01, 2020]. doi:10.5455/njppp.2019.9.0205602032019


AMA (American Medical Association) Style

R DK, A G. Cost variation analysis of various brands of anticoagulants, fibrinolytics, and antiplatelet drugs currently available in Indian pharmaceutical market. Natl J Physiol Pharm Pharmacol. 2019; 9(5): 368-372. doi:10.5455/njppp.2019.9.0205602032019



Vancouver/ICMJE Style

R DK, A G. Cost variation analysis of various brands of anticoagulants, fibrinolytics, and antiplatelet drugs currently available in Indian pharmaceutical market. Natl J Physiol Pharm Pharmacol. (2019), [cited December 01, 2020]; 9(5): 368-372. doi:10.5455/njppp.2019.9.0205602032019



Harvard Style

R, D. K. & A, . G. (2019) Cost variation analysis of various brands of anticoagulants, fibrinolytics, and antiplatelet drugs currently available in Indian pharmaceutical market. Natl J Physiol Pharm Pharmacol, 9 (5), 368-372. doi:10.5455/njppp.2019.9.0205602032019



Turabian Style

R, Deepak K, and Geetha A. 2019. Cost variation analysis of various brands of anticoagulants, fibrinolytics, and antiplatelet drugs currently available in Indian pharmaceutical market. National Journal of Physiology, Pharmacy and Pharmacology, 9 (5), 368-372. doi:10.5455/njppp.2019.9.0205602032019



Chicago Style

R, Deepak K, and Geetha A. "Cost variation analysis of various brands of anticoagulants, fibrinolytics, and antiplatelet drugs currently available in Indian pharmaceutical market." National Journal of Physiology, Pharmacy and Pharmacology 9 (2019), 368-372. doi:10.5455/njppp.2019.9.0205602032019



MLA (The Modern Language Association) Style

R, Deepak K, and Geetha A. "Cost variation analysis of various brands of anticoagulants, fibrinolytics, and antiplatelet drugs currently available in Indian pharmaceutical market." National Journal of Physiology, Pharmacy and Pharmacology 9.5 (2019), 368-372. Print. doi:10.5455/njppp.2019.9.0205602032019



APA (American Psychological Association) Style

R, D. K. & A, . G. (2019) Cost variation analysis of various brands of anticoagulants, fibrinolytics, and antiplatelet drugs currently available in Indian pharmaceutical market. National Journal of Physiology, Pharmacy and Pharmacology, 9 (5), 368-372. doi:10.5455/njppp.2019.9.0205602032019